glp-1-directed nmda receptor antagonism for obesity treatment Eric Topol on X: "The GLP-1 family of drugs have exceeded all expectations, beyond diabetes and obesity. Now there's a pre-clinical GLP-1 and dual drug with many enhanced features that glp-1-directed nmda receptor antagonism for

However, Novo Nordisk (the company that makes Ozempic) promotes weight loss as a benefit in its advertising campaigns

Materials and methods We conducted a double-blind, two-cohort, parallel design, placebo-controlled study to evaluate the safety and efficacy of investigational LC (Carnipure tartrate), in its salt form, L carnitine L-tartrate (LCLT), in adults at risk of SARS-CoV-2-infection (Cohort 1) or disease progression (Cohort 2) in patients with SARS-CoV-2 infection

Carnipure L-carnitine is a clinically studied active lifestyle ingredient that accelerates exercise recovery 1-3 , boosts energy 4-6 and helps improve body composition 5-8 and weight management 9

Formulation note